Evidence map›Paper›PMID 34805192›Full record

SynthesisFrontiers in medicine2021

Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.

Esperanza M Garcia-Oropesa, Yoscelina E Martinez-Lopez, Sonia María Ruiz-Cejudo, José Darío Martínez-Ezquerro, Alvaro Diaz-Badillo, Carlos Ramirez-Pfeiffer, Alejandra Bustamante-Fuentes, Elena B Lopez-Sosa, Oscar O Moctezuma-Chavez, Edna J Nava-Gonzalez and 6 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Esperanza M Garcia-OropesaLaboratorio de Biología Molecular, Unidad Académica Multidisciplinaria Reynosa Aztlán (UAMRA), Universidad Autónoma de Tamaulipas, Reynosa, Mexico.
Yoscelina E Martinez-LopezPrograma de Doctorado en Ciencias Médicas y de la Salud, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Sonia María Ruiz-CejudoUnidad de Investigación Epidemiológica y en Servicios de Salud, Área Envejecimiento (UIESSAE), Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
José Darío Martínez-EzquerroUnidad de Investigación Epidemiológica y en Servicios de Salud, Área Envejecimiento (UIESSAE), Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Alvaro Diaz-BadilloDepartment of Human Genetics, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX, United States.
Carlos Ramirez-PfeifferPrograma de Maestría en Salud Pública, Universidad México-Americana del Norte (UMAN), Reynosa, Mexico.
Alejandra Bustamante-FuentesEscuela de Medicina, Universidad Panamericana, Mexico City, Mexico.
Elena B Lopez-SosaCirugía General, Hospital Español, Mexico City, Mexico.
Oscar O Moctezuma-ChavezAsociación Odontológica Mexicana para la Enseñanza y la Investigación, Mexico City, Mexico.
Edna J Nava-GonzalezFacultad de Salud Pública y Nutrición, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Adriana L Perales-TorresLaboratorio de Bromatología, Unidad Académica Multidisciplinaria Reynosa Aztlán (UAMRA), Universidad Autónoma de Tamaulipas Reynosa-Aztlán, Reynosa, Mexico.
Lucia M Perez-NavarroServicio de Nefrología, Dirección de Investigación, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
Marisol Rosas-DiazLaboratorio de Biología Molecular, Unidad Académica Multidisciplinaria Reynosa Aztlán (UAMRA), Universidad Autónoma de Tamaulipas, Reynosa, Mexico.
Kathleen CarterResearch and Education Library of the School of Medicine, Education & Academic Affairs, University of Texas Rio Grande Valley, Edinburg, TX, United States.
Beatriz TapiaOffice of Faculty Affairs and Department of Pediatrics, School of Medicine, The University of Texas Rio Grande Valley, Harlingen, TX, United States.
Juan C Lopez-AlvarengaDepartment of Human Genetics, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX, United States.
Autonomous University of Tamaulipas · MXThe University of Texas Rio Grande Valley · USMexican Social Security Institute · MXUniversidad México Americana del Norte · MXHospital Español · MXHospital General de México · MXMexican Association for the Clinical Research · MXUniversidad Autónoma de Nuevo León · MXUniversidad Nacional Autónoma de México · MXUniversidad Panamericana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mexicans and Mexican Americans share culture, genetic background, and predisposition for chronic complications associated with obesity and diabetes making imperative efficacious treatments and prevention. Obesity has been treated for centuries focused-on weight loss while other treatments on associated conditions like gout, diabetes (T2D), and hypertriglyceridemia. To date, there is no systematic review that synthesizes the origin of obesity clinics in Mexico and the efforts to investigate treatments for obesity tested by randomized clinical trials (RCT). We conducted systematic searches in Pubmed, Scopus, and Web of Science to retrieve anti-obesity RCT through 2019 and without an inferior temporal limit. The systematic review included RCT of anti-obesity treatments in the Mexican adult population, covering alternative medicine, pharmacological, nutritional, behavioral, and surgical interventions reporting metabolism-associated traits such as BMI, weight, waist circumference, triglycerides, glucose, among others. Only the studies with at least 3 months of treatment were included in the meta-analyses in order to reduce placebo effects. We found 634 entries, after removal of duplicates and screening the studies based on eligibility criteria, we analyzed 43 national, and 2 multinational-collaborative studies. Most of the national studies had small sample sizes, and the implemented strategies do not have replications in the population. The nutrition/behavioral interventions were difficult to blind, and most studies have medium-to-high risk of bias. Nutritional/behavioral interventions and medications showed effects on BMI, waist circumference, and blood pressure. Simple measures like pure water instead of sweet beverages decrease triglycerides and systolic blood pressure. Dark chocolate showed the highest effect for BMI and high blood pressure, and treatment with insulin increased weight in those with T2D. The study of obesity in Mexico has been on-going for more than four decades, the interest on RCT just increased until this millennium, but with small sample sizes and lack of replication. The interventions affect different cardiometabolic associated traits, which should be analyzed in detail in the population living near the Mexico-U.S. border; therefore, bi-national collaboration is desirable to disentangle the cultural effects on this population's treatment response.

Indexed as

abdominal obesity metabolic syndromeanti-obesity agentsrandomized clinical trialssystematic review and meta-analysistype 2 diabetes

Identifiers

PMID34805192
PMCPMC8595206
OpenAlexW3208280087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.